Sažetak
Background: Zinc (Zn) deficiency is a common condition and could contribute to poor outcomes in hemodialysis patients. The aim of this study was to evaluate effects of Zn supplementation on serum copper (Cu) to Zn and CRP to albumin ratios in HD patients.
Methods: Seventy-seven HD patients were enrolled in a multicenter simple-blind randomized clinical trial. Only 37 HD patients completed the study; they were randomly divided into two groups and supplemented with zinc sulfate (n=17) or placebo (n=20) for two months. Serum Zn and Cu were measured by atomic absorption spectrophotometry. Serum albumin and hypersensitive-C-reactive protein were assessed by colorimetric and immunoturbidimetric method, respectively. Determinations were performed before and after the supplementation.
Results and conclusions: After two months of supplementation, serum Zn significantly increased and Cu to Zn ratio decreased in Zn supplemented group, but remained unchanged in placebo group. In parallel, serum albumin concentrations significantly increased and CRP to albumin ratio decreased in Zn supplemented group, only.Zn supplementation reduces Cu to Zn and CRP to albumin ratios in HD patients. These changes point towards an improvement in nutritional, oxidative and inflammatory statuses. The study findings suggest that correcting Zn deficiency reduce poor outcomes in HD patients.
Ključne reči
Reference
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.